| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.29▲ | 2.30▲ | 2.30▲ | 2.44▼ | 2.87▼ |
| MA10 | 2.30▲ | 2.32▲ | 2.32▲ | 2.61▼ | 3.08▼ |
| MA20 | 2.44▼ | 2.50▼ | 2.50▼ | 3.03▼ | 3.18▼ |
| MA50 | 2.79▼ | 2.95▼ | 3.00▼ | 3.18▼ | 13.71▼ |
| MA100 | 3.18▼ | 3.28▼ | 3.23▼ | 3.33▼ | N/A |
| MA200 | 3.26▼ | 3.19▼ | 3.14▼ | 8.56▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.017▲ | 0.010▲ | 0.013▲ | -0.090▼ | 3.711▲ |
| RSI | 39.930▼ | 37.046▼ | 36.865▼ | 32.782▼ | 31.862▼ |
| STOCH | 22.222 | 19.627▼ | 19.627▼ | 8.566▼ | 32.664 |
| WILL %R | -31.818 | -73.684 | -73.684 | -89.197▼ | -90.226▼ |
| CCI | 35.443 | -28.722 | -28.722 | -101.147▼ | -168.397▼ |
|
Sunday, November 16, 2025 02:30 AM
Detailed price information for Exact Sciences Cor (EXAS-Q) from The Globe and Mail including charting and trades.
|
|
Wednesday, November 12, 2025 05:08 AM
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point-of-care ...
|
|
Tuesday, November 11, 2025 01:25 AM
Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that a panel of leading multiple myeloma experts has published clinical ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/11/25 | 2.27 | 2.39 | 2.27 | 2.39 | 6,266 |
| 17/11/25 | 2.30 | 2.32 | 2.195 | 2.31 | 16,600 |
| 14/11/25 | 2.40 | 2.434 | 2.29 | 2.29 | 27,900 |
| 13/11/25 | 2.72 | 2.72 | 2.40 | 2.44 | 41,655 |
| 12/11/25 | 2.758 | 2.902 | 2.70 | 2.75 | 14,600 |
| 11/11/25 | 2.75 | 2.80 | 2.69 | 2.73 | 28,900 |
| 10/11/25 | 2.79 | 2.875 | 2.68 | 2.71 | 26,100 |
| 07/11/25 | 2.81 | 2.87 | 2.67 | 2.74 | 15,500 |
| 06/11/25 | 3.07 | 3.07 | 2.67 | 2.67 | 33,300 |
| 05/11/25 | 3.01 | 3.0986 | 2.95 | 3.05 | 10,557 |
|
|
||||
|
|
||||
|
|